Filing Details

Accession Number:
0000950170-24-076379
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-06-21 17:59:55
Reporting Period:
2024-06-20
Accepted Time:
2024-06-21 17:59:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1593899 Atea Pharmaceuticals Inc. AVIR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1508458 Bruce Polsky 225 Franklin Street
Suite 2100
Boston MA 02110
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2024-06-20 17,544 $3.49 65,606 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Acquisiton 2024-06-21 29,600 $0.00 29,600 $0.00
Common Stock Stock Option (Right to Buy) Acquisiton 2024-06-21 41,200 $0.00 41,200 $3.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
29,600 No 4 A Direct
41,200 2034-06-20 No 4 A Direct
Footnotes
  1. The shares were sold solely to cover taxes upon the vesting of restricted stock units. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.43 to $3.53, inclusive.
  2. Restricted stock units convert into common stock on a one-for-one basis.
  3. The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
  4. The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 21, 2024, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.